Although it is most likely that DPP-4 inhibition prevents GVHD by suppressing donor T cell activation (132), DPP-4 inhibition may mitigate damage to the intestinal epithelium by inhibiting GLP-2 degradation (133). The gene discussed is GCG; the disease is graft versus host disease.